JDJulia Dumfarth

Julia Dumfarth

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Julia Dumfarth has a total of 188 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Sex-Specific Differences in Perioperative Blood Management After Cardiac Surgery: The Role of Haemodilution

    by Nicole Innerhofer, Sasa Rajsic, Pia Tscholl, Corinna Velik-Salchner, Christine Eckhardt, Julia Dumfarth, Lorin Loacker, Barbara Sinner, Judith Martini

    Background/Objectives: Female patients undergoing cardiac surgery receive red blood cell (RBC) transfusions more frequently than male patients, but the mechanisms underlying this disparity remain incompletely understood. Haemodilution during cardiopulmonary bypass (CPB), in the context of lower physiological total blood volume (TBV) and uniform fluid management, may contribute to sex-specific differences in haemoglobin (Hb) trajectories and transfusion exposure. This study investigated whether sex-specific differences in haemodilution contribute to perioperative RBC transfusion exposure in patients undergoing elective cardiac surgery with CPB. Methods: In this secondary analysis of a prospective, single-centre observational cohort study, we included 174 adults undergoing elective coronary artery bypass grafting and/or valve surgery. TBV was estimated using the Nadler formula. Perioperative Hb concentrations, fluid administration and RBC transfusions were recorded from baseline to postoperative day 3. Multivariable regression and mixed-effects models were used to evaluate sex-specific differences in haemodilution and transfusion exposure. The study was registered at ClinicalTrials.gov (NCT05033236). Results: At baseline, Hb concentrations were lower in female than in male patients (12.0 vs. 13.5 g dL−1, p < 0.001). During CPB, female patients exhibited lower Hb concentrations together with a greater relative increase in TBV, consistent with more pronounced haemodilution. RBC transfusions occurred more frequently in female patients both intraoperatively (42.3% vs. 12.3%, p < 0.001) and overall (59.6% vs. 36.1%, p = 0.005). After adjustment for Hb and TBV relative to sex-specific thresholds, CPB duration and surgical procedure type, female patients had 3.9-fold higher odds of receiving at least one RBC unit (odds ratio 3.9, bootstrap 95% CI 1.5–13.3; p = 0.003). Conclusions: Female patients undergoing cardiac surgery experience disproportionate haemodilution and higher transfusion exposure. A dilution-aware, TBV-informed interpretation of Hb concentration may support more individualised and equitable transfusion decision-making.

  • Type B Aortic Dissection in Patients Aged 30 Years or Younger: A Retrospective Multicentre Study

    by Murat Yildiz, Maximilian Luehr, Wei-Guo Ma, Andreas Martens, Arjang Ruhparwar, Quentin Pellenc, Antoine Girault, Selim Mosbahi, Nimesh D Desai, Andreas Polycarpou, et al.

    Objectives: Type B aortic dissection (TBAD) is rare in patients aged ≤30 years, and data on this population remain limited. This study aimed to characterize the underlying aetiology, and outcomes of invasively treated young patients with TBAD, with a focus on the impact of heritable thoracic aortic disease (HTAD). Methods: A retrospective multicentre analysis was conducted across 19 international aortic centres, including 139 patients aged ≤30 years with TBAD. Patients with chronic TBAD (n = 42) were excluded for the final analysis. The cohort was classified as uncomplicated (n = 86) or complicated (n = 53) TBAD. Clinical, radiologic, intraoperative, and postoperative data were collected using standardized forms. Outcomes were compared between subgroups defined by TBAD complexity, HTAD status, and surgical strategy. Kaplan-Meier and Andersen-Gill analyses were used for survival and recurrent aortic intervention, respectively. Results: Mean follow-up time was 6.5 years. HTAD was identified in 57% of patients. Most presented with uncomplicated TBAD (62%), while high-risk uncomplicated cases were uncommon. Endovascular repair was predominant in complicated TBAD, while open repair was more frequent in uncomplicated cases. Early mortality was low (n = 3), and mid-term survival was excellent across all subgroups. HTAD was a significant predictor of recurrent aortic interventions (HR = 3.3, P = .004). No significant differences were observed in survival or reintervention rates between uncomplicated and complicated TBAD or between operative strategies. Conclusions: In young patients, TBAD predominantly occurs in the context of HTAD. Both open and endovascular repair are associated with excellent early outcomes and mid-term survival. However, HTAD remains a significant predictor of recurrent aortic interventions.


  • Open Access

    Minimally invasive mitral valve repair for commissural prolapse: Safety, success, and long-term efficacy

    by Clemens Engler, Leo Pölzl, Felix Nägele, Michael Graber, Jakob Hirsch, Ronja Lohmann, Johannes Holfeld, Julia Dumfarth, Johannes Spilka, Ludwig Müller, et al.

    OBJECTIVES: Commissural prolapse (CP) is a rare and complex mitral valve pathology which is complicated in preoperative diagnosis and repair. This study evaluated the safety, success, and long-term efficacy of minimally invasive mitral valve repair (MIMVR) for CP compared to posterior leaflet prolapse (PMLp). METHODS: Between 2001 and 2022, 34 patients with CP and 590 with PMLp underwent MIMVR at our center. Operative, perioperative, and long-term follow-up data were retrospectively collected. Surgical success was defined as freedom from conversion to valve replacement, sternotomy, and residual mitral regurgitation (MR) > grade I. Long-term efficacy included MR recurrence, reoperation, and survival. RESULTS: Median age was similar (CP: 64.0 years [53.2; 69.8] vs PMLp: 62.0 years [53.0; 69.0], p = 0.783). Barlow’s disease was more frequent in PMLp (80.3% vs 32.4%, p < 0.001). Cross-clamp (127.0 min vs 105.0 min, p = 0.001) and bypass times (208.5 min vs 190.5 min, p = 0.031) were longer in CP. CP patients had longer hospital stays (10.0 days [8.0; 12.0] vs 8.0 days [7.0; 9.0], p < 0.001), but short-term outcomes, including 30-day mortality, stroke, and ECMO support, were comparable. At a median follow-up of 4.5 years (CP) and 2.4 years (PMLp, p = 0.001), rates of recurrent MR, reoperation, and survival were similar. CONCLUSIONS: MIMVR for CP is safe, successful, and durable with outcomes comparable to PMLp. Despite greater technical complexity and longer operative times, this approach provides reliable results for CP.

  • Top Cited Papers

    Thoracic aortic aneurysm

    by Tim Berger, Julia Dumfarth, Maximilian Kreibich, Kenji Minatoya, Bulat A. Ziganshin, Martin Czerny

    Aortic medicine has undergone remarkable progress in recent decades with regard to our understanding and treatment of aortic disease. In the past decade, the scientific community has called for the aorta to be viewed as an independent organ, advocating for a holistic approach to understanding thoracic aortic disease, integrating its embryological development, wall composition, pathophysiological mechanisms, surveillance and treatment. Thoracic aortic aneurysm (TAA) is a potentially fatal disease characterized by abnormal dilation of the thoracic aorta, whereby the structural integrity of the vessel wall is compromised. Although epidemiological studies of TAA are confounded by its asymptomatic nature and diagnostic challenges, available evidence suggests that TAA prevalence and treatment outcomes vary according to race, sex and socioeconomic factors. Pathophysiological mechanisms involve interactions between vascular smooth muscle cells and the extracellular matrix, influenced by genetic predisposition and embryological factors as well as arterial hypertension. Diagnosis relies on advanced imaging techniques, with CT angiography considered to be the gold standard diagnostic tool and with genetic screening recommended for heritable conditions. Preventive measures focus on managing cardiovascular risk factors, whereas treatment includes medical management, as well as endovascular and open surgical repair. TAA has a major effect on quality of life, particularly in younger, female and genetically predisposed patients, necessitating further research and tailored interventions.


  • Open Access

    Predictors and outcomes in patients undergoing surgery for acute type A aortic dissection requiring concomitant venoarterial extracorporeal membrane oxygenation support—a retrospective multicentre cohort study

    by Leonard Pitts, Simone Gasser, Murat Uzdenov, Christopher Gaisendrees, Maris Bartkevics, Maximilian Kreibich, Maximilian Luehr, Jörg Kempfert, Florian Schoenhoff, Volkmar Falk, et al.

    OBJECTIVES: The study’s aim was to investigate the outcomes and risk factors for mortality in patients undergoing surgery for acute type A aortic dissection receiving concomitant venoarterial extracorporeal membrane oxygenation (ECMO) support. METHODS: Patients from 5 European centre who underwent surgery for acute type A aortic dissection and received perioperative venoarterial ECMO support were included. A multivariable binary logistic regression analysis was performed to identify risk factors for 30-day mortality. A receiver operating characteristic curve and restricted cubic splines were designed to investigate the association between pre-ECMO lactate peak and survival. RESULTS: The final cohort comprised 117 patients. Mean time on ECMO support was 3 days (interquartile range 1–7). In 36 patients (31%), successful ECMO weaning was achieved. Thirty-day mortality was 72%, leading cause for early mortality was multiorgan failure (39%). In total, 20% of patients were discharged from hospital. Pre-ECMO lactate peak [odds ratio (OR) 1.02, 95% confidence interval (CI) 1.005–1.032], presence of preoperative shock (OR 9.47, 95% CI 1.749–98.257) and need for total arch replacement (OR 6.628, 95% CI 1.492–33.373) were identified as associates for 30-day mortality. For pre-ECMO lactate peak, the area under the curve showed an acceptable value of 0.73 and restricted cubic splines showed a significant correlation to survival (P = 0.004) with an increased risk above a lactate level of 85 mg/dl. CONCLUSIONS: Venoarterial ECMO support may not be futile but should be well balanced against the high-risk profile in this patient cohort. The pre-ECMO lactate peak is an independent risk factor and a valid predictor of 30-day mortality.


  • Open Access

    Thoracic aortic disease: why sex matters

    by Julia Dumfarth, Simone Gasser, Michael Grimm

    Sex-based precision medicine on ascending aortic dilatation.


  • Open Access

    Valve-Sparing Aortic Root Replacement in Congenital Aortopathy: Long-term Results

    by Simone Gasser, Lukas Stastny, Antonia Valerie Studer, Nikolaos Bonaros, Michael Grimm, Julia Dumfarth


  • Multicentre frozen elephant trunk technique experience as redo surgery to treat residual type A aortic dissections following ascending aortic replacement

    by Maximilian Kreibich, Leonard Pitts, Jörg Kempfert, Murat Yildiz, Florian Schönhoff, Christopher Gaisendrees, Maximilian Luehr, Tim Berger, Till Demal, Joshua Jahn, et al.

    OBJECTIVES: The goal of this project was to assess the efficacy of a reoperative frozen elephant trunk (FET) operation for treating residual type A aortic dissections. METHODS: Between April 2015 and October 2023, a total of 237 patients underwent elective redo surgical aortic arch replacement via the FET technique to treat residual type A aortic dissection in 11 European aortic centres. Data were pooled and analysed retrospectively. RESULTS: The time between an acute type A dissection repair to an FET implant was 5 years. More than half of all patients (54%) presented with an entry within the aortic arch, and 174 patients (73%) presented residual dissections of supra-aortic vessels. During FET repair, the axillary artery was cannulated in 181 patients (76%), whereas 83 patients (35%) underwent additional cardiac procedures including 39 root replacements (16%) and 15 coronary bypass procedures (6%). Zone 2 was the most common arch anastomosis site (n = 163, 69%), and bilateral antegrade cerebral perfusion was most frequent (n = 159, 67%). Fifteen patients (6%) died in-hospital. Age in years (P < 0.001, odds ratio: 1.069) proved to be predictive for overall mortality in our Cox regression model. CONCLUSIONS: Elective redo surgical aortic arch replacement using the FET technique for treating residual type A aortic dissection following ascending aortic replacement revealed a favourable outcome. The decision to undertake stage two therapy of a residually dissected aortic arch should be made by an aortic team on a patient-by-patient basis.


  • Open Access

    Beyond the organ: lung microbiome shapes transplant indications and outcomes

    by Florian Ponholzer, Christina Bogensperger, Felix Julius Krendl, Christoph Krapf, Julia Dumfarth, Stefan Schneeberger, Florian Augustin

    The lung microbiome plays a crucial role in the development of chronic lung diseases, which may ultimately lead to the need for lung transplantation. Also, perioperative results seem to be connected with altered lung microbiomes and its dynamic changes providing a possible target for optimizing short-term outcome after transplantation. A literature review using MEDLINE, PubMed Central and Bookshelf was performed. Chronic lung allograft dysfunction (CLAD) seems to be influenced and partly triggered by changes in the pulmonary microbiome and dysbiosis, e.g. through increased bacterial load or abundance of specific species such as Pseudomonas aeruginosa. Additionally, the specific indications for transplantation, with their very heterogeneous changes and influences on the pulmonary microbiome, influence long-term outcome. Next to composition and measurable bacterial load, dynamic changes in the allografts microbiome also possess the ability to alter long-term outcomes negatively. This review discusses the “new” microbiome after transplantation and the associations with direct postoperative outcome. With the knowledge of these principles the impact of alterations in the pulmonary microbiome in hindsight to CLAD and possible therapeutic implications are described and discussed. The aim of this review is to summarize the current literature regarding pre- and postoperative lung microbiomes and how they influence different lung diseases on their progression to failure of conservative treatment. This review provides a summary of current literature for centres looking for further options in optimizing lung transplant outcomes and highlights possible areas for further research activities investigating the pulmonary microbiome in connection to transplantation.


  • Open Access

    Five-year outcomes of different techniques for minimally invasive mitral valve repair in Barlow’s disease

    by Leo Pölzl, Can Gollmann-Tepeköylü, Felix Nägele, Kardelen Cetin, Johannes Spilka, Johannes Holfeld, Ulvi C Oezpeker, Luka Stastny, Michael Graber, Jakob Hirsch, et al.

    OBJECTIVES: Barlow’s disease is a specific sub-form of mitral valve (MV) disease, characterized by diffuse excessive tissue and multi segment prolapse. The anterolateral mini-thoracotomy represents the standard access for MV regurgitation in many centres. It still remains unclear which surgical technique provides the best results. Therefore, the aim of this study was to compare operative safety and mid-term outcomes after (i) isolated annuloplasty, (ii) use of additional artificial chordae or (iii) leaflet resection in patients suffering from Barlow’s disease undergoing minimally invasive MV repair. METHODS: A consecutive series of patients suffering from Barlow′s disease undergoing minimally invasive MV surgery between 2001 and 2020 were analysed (n = 246). Patients were grouped and analysed according to the used surgical technique. The primary outcome was a modified Mitral Valve Academic Research Consortium combined end-point of mortality, reoperation due to repair failure or reoccurrence of severe mitral regurgitation within 5 years. The secondary outcome included operative success and safety up to 30 days. RESULTS: No significant difference was found between the 3 surgical techniques with regard to operative safety (P = 0.774). The primary outcome did not differ between groups (P = 0.244). Operative success was achieved in 93.5% and was lowest in the isolated annuloplasty group (77.1%). Conversion to MV replacement was increased in patients undergoing isolated annuloplasty (P < 0.001). CONCLUSIONS: Isolated annuloplasty, use of additional artificial chordae and leaflet resection represent feasible techniques in Barlow patients undergoing minimally invasive MV surgery with comparable 5-year results. In view of the increased conversion rate in the annuloplasty group, the pathology should not be oversimplified.